Effect of Irvingia Gabonensis (Bush Mango)on Parameters Associated With Metabolic Syndrome
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00645775|
Recruitment Status : Completed
First Posted : March 28, 2008
Last Update Posted : March 28, 2008
|Condition or disease||Intervention/treatment|
|Metabolic Syndrome Obesity Dyslipidemia||Dietary Supplement: IGOB131|
To assess the effects of seeds of Irvingia gabonensis on body weight, fasting blood glucose, plasma total and LDL cholesterol in 102 overweight and obese participants.
The study was a 10 week randomized, double blind, placebo controlled design. participants were randomly divided into 2 groups of 51 participants each. Group 1 was the placebo group, while Group 2 was the active group. Each group received 2 daily doses of 125 mg (before meals) of either placebo or Irvingia gabonensis.
Weight as well as fasting blood was taken at baseline and at 4, 8 and 10 weeks. No major detary changes or exercises were suggested during the study period.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||102 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||The Efficacy of Irvingia Gabonensis (Bush Mango) in the Management of Overweight, Obesity and Metabolic Syndrome in Cameroon.|
|Study Start Date :||November 2006|
|Primary Completion Date :||March 2007|
|Study Completion Date :||April 2007|
Placebo Comparator: 1
Compare active to placebo
Dietary Supplement: IGOB131
Comparison of 250 mg per day of Irvingia gabonensis to placebo
- Weight change [ Time Frame: 10 weeks ]
- Change in blood lipids and hormone levels [ Time Frame: 10 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00645775
|Laboratory of Nutrition & Nutritional Biochemistry|
|Yaounde, Centre, Cameroon, BP812|
|Study Director:||Julius E Oben, PhD||Gateway Health Alliances / University of Yaounde|